Kim Tae-woo Wins Myunggok Clinical Medicine Award
Kim Eye Hospital presented its fifth Myunggok Clinical Medicine Award to Seoul National University Bundang Hospital ophthalmology professor Kim Tae-woo for his contributions to precision glaucoma care.
This article was automatically drafted and passed editorial compliance checks. It synthesizes public source metadata and is not a substitute for individual care or clinical review.
Seoul National University Bundang Hospital ophthalmology professor Kim Tae-woo received the fifth Myunggok Clinical Medicine Award at the 24th Kim Eye Hospital Symposium. Kim Eye Hospital held the ceremony in its Myunggok Hall on August 9.
Kim was recognized for research supporting precise glaucoma diagnosis and tailored treatment, including work to establish indicators that clinicians can use for diagnosis and prognosis prediction.
What the award recognizes
Kim Eye Hospital established the award in 2022, its 60th-anniversary year, to identify and support physicians who contribute to ophthalmic specialization and the advancement of clinical medicine.
The award evaluates research achievements alongside clinical experience and contributions in patient care. Kim's selection therefore reflects both his glaucoma research and its intended clinical relevance.
Clinical context and limits
The recognition concerns Kim's contribution to glaucoma diagnosis, prognosis prediction, and tailored care. It does not by itself establish how any particular patient should be diagnosed or treated, because individual variation requires assessment by a qualified ophthalmologist.
MK Health and Pharmaceutical News did not describe treatment-specific effectiveness, side effects, or recovery. Patients should consult a qualified ophthalmologist about those issues rather than interpret the award as treatment guidance.
Questions for an eye consultation
A patient discussing glaucoma can ask which examinations support diagnosis and how the clinician evaluates prognosis. The reports identify these as areas of Kim's work but do not specify a test or indicator suitable for every patient.
Patients can also ask how a proposed care plan reflects their own findings and what side effects or recovery considerations may apply. A qualified ophthalmologist can relate those questions to the patient's examination and individual variation.
Frequently asked questions
What award did Kim Tae-woo receive?
Kim Tae-woo received the main prize of the fifth Myunggok Clinical Medicine Award. Kim Eye Hospital presented it at the 24th Kim Eye Hospital Symposium on August 9.
Why was Kim Tae-woo selected for the award?
Kim was recognized for contributing to precision glaucoma care through research on accurate diagnosis and tailored treatment. His work also included establishing clinically usable indicators for diagnosis and prognosis prediction.
What does the Myunggok Clinical Medicine Award evaluate?
Kim Eye Hospital evaluates research achievements together with clinical experience and contributions to patient care. The hospital established the award in 2022 to support physicians contributing to ophthalmic specialization and clinical medicine.
Glaucoma consultation checklist
- Which examinations are being used to assess whether I have glaucoma?
- How will you evaluate my prognosis from the examination findings?
- How is the proposed care plan tailored to my individual findings?
- What side effects and recovery considerations should I discuss for any proposed treatment?
MediIndex articles are for general information only and are not medical advice, diagnosis, or advertising. Outcomes vary by individual — consult a board-certified specialist for personal decisions.
